Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy
NCT06711185
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Dapagliflozin 10 mg
OTHER:
Placebo
Sponsor
University of Campinas, Brazil